Christopher Leggett

Christopher (Chris) Leggett is the Lead for Global Commercial Innovation at Genmab. Genmab is a biotechnology company specializing in the creation and development of novel antibody therapies targeting cancer and other serious diseases. As the Lead for Global Commercial Innovation, Chris is responsible for identifying and implementing differentiated capabilities to enhance provider and patient experience. He is focused on leveraging digital health solutions to transform the customer journey from clinical development through commercialization.

Chris has extensive industry experience in marketing, public policy, market access, and healthcare innovation. Prior to joining Genmab, he led the Immunology Market Access Marketing team at Janssen and established the Commercial Innovation function at Novo Nordisk, Inc. Chris earned a BA in Political Science and MBA from Loyola University Maryland.